Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,436 | 26,882 | 27,273 | 18,649 | 17,695 |
| Receivables | 10,101 | 7,551 | 4,704 | 10,737 | 19,165 |
| Inventories | 5,950 | 6,981 | 5,780 | 6,725 | 5,008 |
| TOTAL | $39,788 | $43,706 | $39,888 | $38,087 | $43,505 |
| Non-Current Assets | |||||
| PPE Net | 4,602 | 3,814 | 4,085 | 4,284 | 4,569 |
| Intangibles | 1,357 | 1,396 | 1,435 | 1,487 | 25 |
| Other Non-Current Assets | 11,247 | 12,369 | 11,662 | 7,987 | 8,211 |
| TOTAL | $17,206 | $17,579 | $17,182 | $13,758 | $12,805 |
| Total Assets | $56,994 | $61,285 | $57,070 | $51,845 | $56,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,051 | 29,635 | 9,946 | 25,297 | 18,637 |
| Accrued Expenses | 4,263 | 4,508 | 7,967 | 7,733 | 7,042 |
| Other current liabilities | 1,000 | 1,147 | 1,147 | 1,910 | 1,445 |
| TOTAL | $38,653 | $40,383 | $39,528 | $36,560 | $29,636 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,801 | 25,196 | 33,448 | 38,675 | 43,821 |
| Deferred Revenues | 3,992 | 4,765 | 1,513 | 774 | 1,599 |
| Other Non-Current Liabilities | 71,071 | 71,902 | 71,231 | 66,807 | 65,720 |
| TOTAL | $124,992 | $130,137 | $136,096 | $123,104 | $123,031 |
| Total Liabilities | $163,645 | $170,520 | $175,624 | $159,664 | $152,667 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,727 | 55,922 | 55,871 | 54,156 | 53,351 |
| Common Shares | 62 | 56 | 55 | 54 | 53 |
| Retained earnings | -308,931 | -303,139 | -311,207 | -298,855 | -286,318 |
| TOTAL | $-106,651 | $-109,235 | $-118,554 | $-107,819 | $-96,357 |
| Total Liabilities And Equity | $56,994 | $61,285 | $57,070 | $51,845 | $56,310 |